The purpose of this study is to validate a left-right design with respect to detecting a difference in efficacy after 3 weeks of treatment between an active treatment and a vehicle in adults with mild to moderate atopic dermatitis
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Enrollment
30
bioskin GmbH
Hamburg, Germany
Evaluation of the treatment effect defined as total sign score on the treated area at end of the 3 weeks treatment period
Time frame: 3 weeks
Incidence of adverse events during the 3 weeks treatment period
Time frame: 3 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.